Skip to main content
WuXi AppTec Co., Ltd. logo

WuXi AppTec Co., Ltd. — Investor Relations & Filings

Ticker · 2359 ISIN · CNE100003F19 LEI · 254900OEPQLZSPLN9175 HKEX Professional, scientific and technical activities
Filings indexed 1,741 across all filing types
Latest filing 2025-08-06 Transaction in Own Shar…
Country CN China
Listing HKEX 2359

About WuXi AppTec Co., Ltd.

http://www.wuxiapptec.com.cn

WuXi AppTec Co., Ltd. is a global Contract Research, Development, and Manufacturing Organization (CRDMO) dedicated to enabling the pharmaceutical and life sciences industries. The company provides an integrated, open-access capability and technology platform to accelerate the discovery, development, and manufacturing of innovative therapies. Core services encompass a broad portfolio of R&D solutions, including discovery biology (hit finding, oncology services), analytical testing, and clinical research services. Utilizing its end-to-end CRDMO model, which includes specialized platforms like WuXi STA for pharmaceutical development and manufacturing, WuXi AppTec partners with clients globally to advance new medicines from concept through commercialization.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is an FF305 “Next Day Disclosure Return” filed to the Hong Kong Exchange pursuant to its listing rules, detailing the daily changes in issued shares and treasury shares and enumerating the company’s on‐market repurchases (buybacks) of its own A shares. This is not an annual report, earnings release, or governance statement but a detailed log of share repurchase transactions. Under our taxonomy, such reports fall under “Transaction in Own Shares” (POS) rather than a general capital change announcement (SHA) or fallback RNS.
2025-08-06 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 91% confidence The document is an exchange filing (Next Day Disclosure Return FF305) required under the Hong Kong Main Board/GEM listing rules, detailing a series of on-market share repurchases by the issuer (WuXi AppTec). It contains multiple entries of shares repurchased (dates, quantities, prices) and confirms compliance with listing rules. This is a regulatory report of the company buying back its own shares, matching the definition of a “Transaction in Own Shares.”
2025-08-05 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a regulatory "Next Day Disclosure Return" (Form FF305) filed by WuXi AppTec under Hong Kong Listing Rules, detailing share buyback transactions (changes in issued shares and treasury shares) over a series of dates. It is neither an announcement of a broader financial report nor a management or earnings release, but rather a detailed schedule of on‐market repurchases of the company’s own shares. This matches the "Transaction in Own Shares" category (Code: POS).
2025-08-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025
Transaction in Own Shares Classification · 85% confidence The document is HKEX Form FF301 – a Monthly Return for Equity Issuer and Hong Kong Depositary Receipts detailing movements in authorised/registered share capital, issued shares, treasury shares and extensive repurchase (buyback) data. It is a regulatory filing primarily reporting on the company’s own share transactions (repurchases) rather than a general capital-raising or split announcement. Therefore, it best fits the “Transaction in Own Shares” category.
2025-08-04 English
List of Directors and their Roles and Functions
Governance Information Classification · 85% confidence The document provides a structured list of the company’s board members and the composition of its board committees, detailing roles and governance structure rather than announcing a specific management change or financial results. This aligns with a Governance Information report (CGR) describing board structure and internal governance practices, rather than a change announcement (MANG) or other category.
2025-07-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.